Thorne HealthTech (NASDAQ: THRN), a New York-based company developing solutions for a personalized approach to health and wellness, acquired PreCon Health, a company focused on scientific discovery, safe and effective products that support healthy brain function.
The amount of the deal was USD5M.
With the acquisition, Thorne HealthTech will expand its brain health portfolio.
PreCon Health is principally focused on developing solutions to address the unmet needs relative to brain health. The company works for brain health research establishing an ecosystem of safe, research-based brain health products in support of consumers, patients, healthcare providers, athletes, military personnel, and survivors of domestic violence.
Led by CEO Paul Jacobson, Thorne HealthTech is a company developing solutions for delivering personalized approaches to health and wellness. The company utilizes testing and data to create improved product efficacy and to deliver personalized solutions to consumers, health professionals, and corporations. Thorne leverages artificial intelligence models to provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improve and maintain their health over a lifetime.
Thorne and PreCon first partnered together in 2021 to bring the first multi-ingredient dietary supplement formulated to support pre- and post-impact brain health, SynaQuell ™ and SynaQuell+ ™, to market.
FinSMEs
08/02/2023